SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX: 1777)
Health Care · Pharmaceuticals · TW
NT$74.10
-0.54% today · -2.0% 1Y
SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX: 1777) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $103.77M and employs 223 people.
Over the last twelve months the share price has lost 2.0%, trading between 70.00 and 80.00.
Tweenvest scores SYN-TECH Chem. & Pharm. Co., Ltd. across four factors: quality 83/100, value 67/100, growth 35/100, dividend 91/100. Its strongest factor is dividend.
1777 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $103.77M
- Revenue (TTM)
- $39.97M
- P/E
- 10.00
- EPS
- 7.41
- Dividend yield
- 5.40%
- Beta (5Y)
- -0.10
- 52-week high
- NT$80.00
- 52-week low
- NT$70.00
- Avg volume (3M)
- —
- Shares outstanding
- 44.59M
- Employees
- 223
- Next earnings
- —
About SYN-TECH Chem. & Pharm. Co., Ltd.
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulcerative, antihypertensive, a-blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, pharmaceutic aid/lubricant, antiglaucoma agent, hyponatremia, antidepressant, sedative, and analgesic, as well as treatment for hyperparathyroidism and urinary frequency, benign prostatic hypertrophy, and Herpes virus helicase-primase inhibitor. SYN-TECH Chem. & Pharm. Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.
- ISIN
- TW0001777001
- Founded
- 1982
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,232.30 | -1.17% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $272.64 | -0.15% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.40 | +3.81% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.52 | +1.97% |
Figures last refreshed Aug 18, 2026.